Arkolith/Insider Trading/BCRX/Form 4

Barnes Alane P

Chief Legal OfficerBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Dec 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2025Sell(S)20K$7.65$151K345K
Dec 2, 2025Sell(S)51K$7.21$367K365K
Dec 1, 2025Option exercise(M)91K$3.22$293K507K
Dec 1, 2025Sell(S)91K$7.10$646K416K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2025Option exercise(M)91K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-25-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML